Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal Calprotectin Levels, Quality of Life and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

NCT02092389 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02092389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02092389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal Calprotectin Levels, Quality of Life and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo
Lead sponsor
AbbVie
Phase
Observational
Overall status
Terminated
Start date
July 31, 2014
Completion date
March 31, 2016
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe ulcerative colitis